Health Canada inspection
Novartis Pharma AG: Health Canada inspection of Dec 18, 2025
Health Canada · GMP · rating C
Key facts
| Establishment | Novartis Pharma AG |
|---|---|
| City | Basel |
| Country | Switzerland |
| Program | GMP |
| Start date | Dec 18, 2025 |
| Rating | C |
| Rating description | Compliant |
| Licence number | Not applicable |
At a glance
- 1–9 Inspections of this establishment
- No Currently licensed
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Health Canada inspections
Health Canada inspects establishments that conduct licensable activities with drugs, including good manufacturing practices (GMP) and pharmacovigilance (GVP) inspections. Clinical trial (GCP) inspections, which name individuals, are not published here.